Mix of therapies shown to extend life, #AIDS2016 told

Published Jul 21, 2016

Share

Durban - People in poor countries are six to 10 times more likely to die because of Aids when their immune systems are compromised than people in the same position in wealthy countries.

But according to a new study presented on Wednesday at the 21st International Aids Conference in Durban, a simple combination of prevention drugs given at the same time as antiretroviral therapy (ART) can reduce deaths in sick Aids patients by a quarter.

During the Reality study – conducted in Uganda, Malawi, Kenya and Zimbabwe – 906 patients who were diagnosed with HIV late were given five additional drugs to prevent other infections. A further 899 in the control group received just one prevention drug.

The five extra prophylactic drugs comprised cotrimoxazole and azithromycin (for bacterial infections), isoniazid (for TB), fluconazole (for fungal infections) and albendazole (for parasitic worms).

The patients were all sick from HIV with CD4 counts (a measure of a person’s immunity) of below 100.

“The patients are often poor and malnourished in these settings with a high risk of TB,” said Professor James Hakim, who heads the Department of Medicine at the University of Zimbabwe College of Health Sciences in Harare.

Hakim said that while the scale-up of antiretroviral therapy around the world was exciting, there was “an important difference in outcomes for patients on ART in resource-rich versus resource-limited countries”.

“There is very high mortality from infections in the first six months of ART in HIV-infected people with advanced disease in sub-Saharan Africa,” said Hakim.

The prophylactic package reduced deaths by 25 percent by preventing a range of infections and marginally reduced the number of patients needing to be hospitalised.

Hakim urged policymakers to consider the low-cost broad infection prevention package. "For every 100 individuals treated, 3.3 lives could be saved."

ART is a combination of three HIV medicines taken daily and can increase an HIV-positive person’s life expectancy to almost normal levels, as long as it is received in time.

Health-e News

Related Topics: